T Cell Manufacturers, Suppliers & Companies
-
Manufacturerbased in Seattle, WASHINGTON (USA)
We believe we are entering a new era of medicine. The ability to modify genes and use cells as medicines provides new tools to meaningfully change the outcome of many human diseases. Early pioneers have made good progress, but most of what we can ...
Sana - Model SG221 (CD4/BCMA) - T cells - Fusogen Technology
Oncology: Multiple ...
CONTACT SUPPLIER -
Manufacturerbased in Philadelphia, PENNSYLVANIA (USA)
Adaptimmune, a leader in T-cell therapy, has clinical trials ongoing for three wholly owned SPEAR T-cells (ADP-A2M4, ADP-A2M4CD8, and ADP-A2AFP) in multiple solid tumor indications. The Company's unique SPEAR (Specific Peptide Enhanced Affinity ...
Adaptimmune - Model ADP-A2M4 (MAGE-A4) - Spear T-Cell Therapy
Our ADP-A2M4 (MAGE-A4) SPEAR T-cell therapy is directed to a member of the MAGE family of cancer testis antigen expressed in a number of solid tumor cell types. The MAGE- A4 antigen is among the ...
CONTACT SUPPLIER -
Technologybased in Carlton South, AUSTRALIA
Chimeric Therapeutics is a clinical stage cell therapy company focused on bringing the promise of cell therapy to life for more patients with cancer. We believe that cellular therapies have the promise to cure cancer not just delay disease ...
Chimeric - Model CHM 2101 (CDH17 CAR T) - T Cells for Derived Autologous Therapies
CHM 2101 (CDH17 CAR T) is an optimized 3rd generation CAR T cell therapy that is the first to target ...
CONTACT SUPPLIER -
Manufacturerbased in Vancouver, BRITISH COLUMBIA (CANADA)
Precision NanoSystems is a global leader in technologies, solutions and services for the development of non-viral delivery of genomic medicines, including mRNA vaccines and therapeutics. We work with the world’s leading drug developers to understand ...
NanoAssemblr Ignite - Lipid Nanoparticle T Cell Kit (LNP) for mRNA
Lipid nanoparticle (LNP) based technology enables researchers to establish a clinically relevant, scalable method for ex vivo gene ...
CONTACT SUPPLIER -
Manufacturerbased in Waltham, MASSACHUSETTS (USA)
AlloVir is the global leader in developing VST immunotherapies. We develop highly innovative, allogeneic, off-the-shelf, virus-specific T cell (VST) therapies designed to prevent and treat life-threatening viral diseases. AlloVir is a leading late ...
Model Posoleucel (Viralym-M, ALVR105) - Multi-Virus Specific T cell Therapy (VST)
Posoleucel targets five devastating viral pathogens: BK virus (BKV), Cytomegalovirus (CMV), Adenovirus (AdV), Epstein-Barr Virus (EBV), and Human Herpesvirus 6 (HHV-6), and has the potential to transform care for transplant recipients. ...
CONTACT SUPPLIER -
Technologybased in San Francisco, CALIFORNIA (USA)
We were founded with the mission of creating a world without infectious disease. We are a commercial-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. ...
T Cell Platform
We are exploiting the unique immunology of human cytomegalovirus, or HCMV, a commonly occurring virus in humans, as a delivery vehicle – or vector – for vaccines to potentially treat and prevent infection by pathogens that are refractory ...
CONTACT SUPPLIER -
Manufacturerbased in New York, NEW YORK (USA)
IN8bio was founded in 2016 with the mission of developing novel therapies to address cancer. The company is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T-cell product ...
DeltEx DRI CAR-T - Model INB-300 - Gamma-Delta T Cells
INB-300, our DeltEx DRI CAR-T, is a preclinical product candidate combining our expertise in gamma-delta T cells, our DRI technology and a novel CAR-directed against the Cholotoxin peptide. ...
CONTACT SUPPLIER -
Manufacturerbased in Holytown, UNITED KINGDOM
We are developing safer, less expensive CAR-T products which can target more cancers and save more lives. We do this using our integrated model which drives the development of our products through preclinical testing to the clinic. Our mission is to ...
Gamma Delta T Cells
Our therapies are focused on leveraging the inherent biological capabilities of gamma delta T cells (GDT cells) together with an integrated cell engineering approach. GDT ...
CONTACT SUPPLIER -
Technologybased in Hayward, CALIFORNIA (USA)
We are a biotech startup in the San Francisco Bay Area founded in February 2017. We focus on developing complex antibodies with enhanced efficacy, safety, and manufacturability features against difficult-to-treat diseases including cancer, ...
T cell Engager Bispecific Antibodies
Bispecific antibodies with computationally optimized differential binding affinities, biochemical and biophysical features, and a common light ...
CONTACT SUPPLIER -
Technologybased in SALUGGIA, ITALY
We are global leader in the laboratory diagnostics market, specializing in the immunodiagnostics and molecular diagnostics segments. For over 50 years we have been dealing with diagnostics to help physicians and patients make better decisions in the ...
diasorin - Model LymeDetect - Unique Diagnostic Value of B Cells Combined With T Cells
through a unique combination of humoral and cell mediated immunity. The unique diagnostic value of B cells combined with T cells. LIAISON® LymeDetect® is an innovative ...
CONTACT SUPPLIER -
Manufacturerbased in Duisburg, GERMANY
Genekam Biotechnology AG was found in 1999. It started offering DNA-Tests in 2001. From 2004, it started development of PCR kits while exporting to 5 countries, today (2015) it exports to 70 countries in the world. Genekam covers different targets ...
T-cell Immunotherapy Solution - Car T-cell Therapy Services
There are many laboratories developing CAR T-cell therapies. Genekam has a number of kits to develop CAR T-Cell therapy e.g. isolate large number of T ...
CONTACT SUPPLIER -
Manufacturerbased in Chuo-ku, JAPAN
Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are ...
Gamma Delta T Cells
Adaptate Biotherapeutics is focussed on therapeutic antibodies which harness the potential of patients’ own gamma delta T cells in situ. Gamma delta T cells play a ...
CONTACT SUPPLIER -
Manufacturerbased in Aberdeen, CHINA
Over the last 10 years, Creative Biolabs has become a leader of recombinant antibody (rAb) discovery and manufacturing, providing high quality service to customers in academia and industry fields all over the world. Creative Biolabs was founded by ...
γδ T Cell Receptors Services
Creative Biolabs is supported by an advisory board with seasoned professionals in gamma delta T cell receptors (γδ TCR) studies, γδ T cell immunologic analysis, as well as γδ ...
CONTACT SUPPLIER -
Manufacturerbased in Menlo Park, CALIFORNIA (USA)
Adicet is a biotechnology company engaged in the development of first-in-class off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet has developed a proprietary cell platform process to activate, engineer and ...
Gamma delta T cells
Gamma delta T cells represent a new generation of universal cell therapy. The current engineered autologous alpha beta T cell products have shown significant ...
CONTACT SUPPLIER -
Manufacturerbased in Florham Park, NEW JERSEY (USA)
Celularity, headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by delivering off-the-shelf allogeneic placenta-derived cellular therapies at unparalleled scale, quality and ...
Celularity - Model CAR-T - Chimeric Antigen Receptor T Cells
Chimeric Antigen Receptor T cells (CAR-T) are genetically engineered T cells that are modified to express an artificial T cell ...
CONTACT SUPPLIER -
Manufacturerbased in Seattle, WASHINGTON (USA)
window into the adaptive immune system the world hadn’t thought possible. Together, Harlan and his brother Chad, founded Adaptive to meet the worldwide demand for immunosequencing technology. Over the past decade, we have developed our proprietary ...
Adaptive - Model TruTCR - Drug Discovery T-Cell Therapy for Cellular Therapy
We are currently leveraging our TCR discovery capabilities to enable commercialization of novel therapies by collaborators. In the future, we may explore expanding our end-to-end capabilities for the development of cellular therapies and vaccines. ...
CONTACT SUPPLIER -
Technologybased in Paris, FRANCE
The mission of Alderaan Biotechnology is to develop novel therapies to treat cancer by targeting cells from the immune system. Alderaan Biotechnology programs are related to the elimination of Regulatory T cells and to the hyper activation of ...
Model CD25 - Regulatory T Cells
Regulatory T cells (Tregcells) represents a cell population with strong immunosuppressive activities. In cancer patients, Treg cells can dampen protective immune responses against ...
CONTACT SUPPLIER -
Technologybased in Oxford, UNITED KINGDOM
Vaccitech is a clinical stage T cell immunotherapy and vaccine company developing products to treat and prevent infectious disease and cancer. The company’s proprietary heterologous prime-boost platform comprises Chimpanzee Adenovirus Oxford ...
Vaccines and T cell Immunotherapies Technology
The patented Vaccitech adenovirus vectors are known as chimpanzee adenovirus Oxford 1 and 2 (ChAdOx1 and ChAdOx2), and are in the group E simian adenovirus family, similar to the widely-studied chimpanzee adenovirus 63. These viruses have been ...
CONTACT SUPPLIER -
Manufacturerbased in Sherman Oaks, CALIFORNIA (USA)
T-Cure is a clinical-stage immuno-oncology company developing the next generation of T cell therapies for patients with solid tumors. It is committed to bringing new targets and therapies to the T-Cell Receptor (TCR) field that have a high ...
T-Cure - Receptor Therapy T Cell
T cell engineering with TCRs is a growing area of immuno-oncology with recent breakthroughs in clinical settings. The T-Cure approach involves identifying and isolating a high avidity TCR which ...
CONTACT SUPPLIER -
Technologybased in São Paulo, BRAZIL
Celluris is the first company in Latin America to develop personalized treatment for cancer patients through CAR-T immunotherapy. This technique is based on the modification of the patient’s own cells into recognizing the tumor as a target, fighting ...
Model CAR-T - Chimeric T Cell Antigen Receptor Therapy
The chimeric T cell antigen receptor therapy, also known as CAR-T, is an immunotherapy that is innovating the treatment of hematological and solid tumors. This new technology is considered less ...
CONTACT SUPPLIER
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you